Glycomine, Inc.
Biotechnology company · San Francisco, California, United States
Glycomine, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $4.9 million sold in a notice filed in 2016.
Glycomine at a glance
What does Glycomine do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.9 million sold (2016).
Frequently asked questions about Glycomine
Where is Glycomine headquartered?
Glycomine, Inc. is headquartered in San Francisco, California, United States.
What does Glycomine do?
Glycomine, Inc. is a biotechnology company.
When was Glycomine founded?
The earliest incorporation on record for Glycomine, Inc. is in 2014, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences